Add To Watchlist
Share URL
About The Company
CEO
Mr. Blaise Coleman
Market Cap
NaN undefined USD
Sector
Healthcare
Website
https://www.endo.comLast Update
2/22/2024, 12:00:00 PM
Description
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally.
Read More
Overview
Value
1
Growth
2
Health
38
Management
46
Analyst Opinion
57
Total
29
All Scores Out Of 100
Best Features
- Earnings growth has improved recently
- Has a low level of debt
- Low preportion of income is paid as dividend
Risk Factors
- Overvalued on cashflow basis
- Earnings are negative
- There is a history of diluting shareholders
- Disliked by Twitter users
- Poor earnings and cashflow growth
- Dividend could be at risk
Market Peers
ENDP
Key Figures
PE Ratio (TTM)
N/A
Margin Of Safety (DCF)
N/A
Revenue Growth (5 Year Average)
-1.44%
Ratings Consensus
Neutral
Share Buybacks
-0.25%
Dividend Yeild (TTM)
N/A
Valuation
Value Score
1
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: N/ANaNNaN
Current Price: 0.4 USD
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
N/Ax
Free Cashflow Yeild
N/A
PE/Earnings Growth
N/A
Price/Book
Infinityx
Growth
Growth Score
2
- ✔ Earnings growth has improved this year
- ✔ Free Cashflow growth has improved this year
- ✘ 5 Year Average Revenue growth of -1.44% is lower than the market average (10.97%)
- ✘ Revenue growth has slowed this year
- ✘ 5 Year Average Earnings growth of -24.56% is lower than the market average (14.48%)
- ✘ 5 Year Average Free Cashflow growth of -20.74% is lower than the market average (12.35%)
Revenue Growth
-1.44%
Earnings Growth
-24.56%
Cashflow Growth
-20.74%
Health
Health Score
38
Altman Z Score
N/A
Piostroski Score
N/A
Debt/Equity
0.00x
Current Assets/Liabilities
1.86x
Free Cashflow/Total Debt
0.02x
Debt/Capital
3.68x
Dividend
Secure Dividend Score
0
- ✔ Long term dividend payout ratio of 0.00% is considered good
- ✔ Payout ratio (TTM) of 0.00% is lower than the average (40%)
- ✔ Dividends have shown growth over the last 5 years
- ✔ Spending a lower percentage of their income on dividends than last 5 years
- ✘ Dividend yeild of N/A is less than the market average (1.85%)
- ✘ Very unsafe
Dividend Yeild
N/A
Dividend Growth
0.00%
Payout Ratio (Earnings)
0.00%
Payout Ratio (Cashflow)
0.00%
Management
Management Score
46
Average Buybacks/Dilution
-0.25%
Recent Buybacks/Dilution
-100.00%
5 Year Price Volitility
60.54%
Return On Assets
0.00%
Return On Capital Employed
-26.88%
Return On Equity
0.00%
Return On Free Cashflow
N/A
Return On Investments
N/A
Analysts
Analyst Opinion
57
- ✔ Ratings consensus is Neutral
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Endo International plc
Currency
USD
Beta
1.153314
Vol Avg
0
Ceo
Mr. Blaise Coleman
Cik
0001593034
Cusip
Exchange
NASDAQ Global Select
Full Time Employees
3103
Industry
Drug Manufacturers—Specialty & Generic
Sector
Healthcare
Ipo Date
2014-03-03
Address
Minerva House, Simmonscourt Road
City
DUBLIN
State
DUBLIN
Country
IE
Zip
4
Phone
35312682000
Analysis Last Updated
2/22/2024, 12:00:00 PM
All financial data provided by FMP
Social Sentiment
Social Sentiment Score
0
Twitter Sentiment
N/A
Stocktwits Sentiment
N/A